These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of massive transfusion during liver transplantation on rejection and infection. Rouch DA; Thistlethwaite JR; Lichtor L; Emond JC; Broelsch CE Transplant Proc; 1988 Dec; 20(6):1135-7. PubMed ID: 3059596 [No Abstract] [Full Text] [Related]
23. Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy. Seghatchian J; Samama MM Transfus Apher Sci; 2012 Oct; 47(2):235-43. PubMed ID: 22770808 [TBL] [Abstract][Full Text] [Related]
24. Effect of aprotinin on coagulation parameters in liver transplantation. Welte M; Groh J; Azad S; Anthuber M; Haller M; Kratzer MA Semin Thromb Hemost; 1993; 19(3):297-9. PubMed ID: 7689755 [No Abstract] [Full Text] [Related]
25. Hemorrhage and coagulopathy in the critically ill. Paterson TA; Stein DM Emerg Med Clin North Am; 2014 Nov; 32(4):797-810. PubMed ID: 25441035 [TBL] [Abstract][Full Text] [Related]
27. Risk factors for intraoperative massive transfusion in pediatric liver transplantation: a multivariate analysis. Jin SJ; Kim SK; Choi SS; Kang KN; Rhyu CJ; Hwang S; Lee SG; Namgoong JM; Kim YK Int J Med Sci; 2017; 14(2):173-180. PubMed ID: 28260994 [No Abstract] [Full Text] [Related]
28. Correction of blood coagulation dysfunction and anemia by supplementation of red blood cell suspension, fresh frozen plasma, and apheresis platelet: results of in vitro hemodilution experiments. Li L; Yang J; Sun Y; Dang Q; Xu C; Chen P; Ma T; Ren J J Crit Care; 2015 Feb; 30(1):220.e1-12. PubMed ID: 25316528 [TBL] [Abstract][Full Text] [Related]
34. Massive transfusion and nonsurgical hemostatic agents. Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic problems after massive blood transfusions]. Wendt M; Lawin P; Götz E Infusionsther Klin Ernahr; 1979 Dec; 6(6):325-9. PubMed ID: 396253 [TBL] [Abstract][Full Text] [Related]
36. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Frasco PE; Poterack KA; Hentz JG; Mulligan DC Anesth Analg; 2005 Jul; 101(1):30-7, table of contents. PubMed ID: 15976201 [TBL] [Abstract][Full Text] [Related]
37. A guide to blood groups, transfusion and coagulation. Sharp S Br J Perioper Nurs; 2004 Jan; 14(1):16-20. PubMed ID: 14768122 [TBL] [Abstract][Full Text] [Related]
38. iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial. Baksaas-Aasen K; Gall L; Eaglestone S; Rourke C; Juffermans NP; Goslings JC; Naess PA; van Dieren S; Ostrowski SR; Stensballe J; Maegele M; Stanworth SJ; Gaarder C; Brohi K; Johansson PI Trials; 2017 Oct; 18(1):486. PubMed ID: 29047413 [TBL] [Abstract][Full Text] [Related]